# Autonomous Agentic AFTERNOON Scan — 2026-08-21

- Timestamp: 2026-08-21T17:31:09Z / 13:31 ET
- Account: Robinhood Agentic ••••1041 (433711041) only
- Mode: pre-authorized autonomous equities-only management
- Policy: `playbook/autonomous-policy.md` ACTIVE; no date-specific plan found
- Decision: HOLD MA, BAC, XOM, SHOP; NO NEW ORDER / NO ROTATION

## Broker, fills, orders, and kill switches

- Account is active, cash, and `agentic_allowed=true`; no other account was operated.
- Account value $327.7700; equity value $313.8100; cash and authoritative buying power $13.96; unsettled funds $0.
- Kill switch clear: value > $10. Value is above the 2026-08-20 afternoon/power-hour snapshots, so available evidence does not show a 5% daily or 10% recent-high drawdown trigger. Broker/tool/risk state was sufficiently certain for management.
- Positions verified: MA 0.113541 @ $572.48; BAC 1.046363 @ $62.12; XOM 0.332975 @ $167.67; SHOP 0.862075 @ $144.09. All quantities are available to sell.
- Latest fill verified: agentic BUY XOM $55.83, filled 0.332975 @ $167.6699 at 2026-08-20T17:32:05.639Z, fees $0, order 6a873a15-714d-4084-8d06-a634a4a502df.
- Open-ish states checked separately (`new`, `queued`, `confirmed`, `unconfirmed`, `partially_filled`): all empty.
- No options, shorts, averaging down, stop widening, or pending orders.

## Market/sector regime

- **Mixed/risk-on rebound, with rotation rather than uniform leadership.** Live: SPY $765.80 (+0.42%), QQQ $713.44 (+0.35%), IWM $299.695 (+0.68%). Prior completed session: SPY above SMA20/SMA50; IWM near SMA20 and above SMA50; QQQ above SMA20 but slightly below SMA50. This is constructive but not a clean all-index trend regime.
- Sector tape: healthcare +1.38%, discretionary +1.22%, financials +0.68%, industrials +0.27%, technology +0.08%; energy -0.09% and semiconductors -0.71%. The broad rebound follows a week pressured by elevated Treasury yields and geopolitical tension; current reporting also points to strong Q2 earnings/2027 outlook support but persistent oil/inflation/rate volatility.
- Fresh entry discipline remains important: several leaders (PLTR, COP, HOOD) are at/near breakout highs or large one-day extensions without a confirmed retest.

## Ranked position decisions

1. **MA — HOLD, 14/16.** Live $580.29; marked value ~$65.89; unrealized +$0.89 (+1.36%). Above rising SMA20 $566.21/SMA50 $535.85 with +8.2% 20-day and +16.4% 60-day momentum. Q2 EPS $5.04 beat $4.76; revenue rose 14%, EPS 21%, and operating margin improved. Price is near $583.71 resistance, so no add. Stop/invalidation $561; targets $584 then $601.77.
2. **SHOP — HOLD/protect, 14/16.** Live $149.085; value ~$128.52; unrealized +$4.31 (+3.47%). Above SMA20 $139.15/SMA50 $125.76 with +31.4%/+40.3% momentum and continued relative strength. Q2 revenue +34%, GMV +32%, and 18% FCF margin support the catalyst. High ~99x P/E and ~5% ATR argue against adding. Stop $140 (not widened); targets $158.85/$170.
3. **XOM — HOLD, 12/16.** Live $165.19; value ~$55.00; unrealized -$0.83 (-1.48%). Still above rising SMA20 $157.92/SMA50 $148.68 with +5.9%/+10.9% momentum; Q2 operating cash flow $23.6B and FCF $17.2B support quality. Today XLE and XOM lag, but the $163.50 binding invalidation has not broken. No averaging down. Stop $163.50; targets $176.50/$182; 3–5-session time stop remains active.
4. **BAC — HOLD but weakest, 10/16.** Live $61.545; value ~$64.40; unrealized -$0.60 (-0.93%). Below SMA20 $63.04 but above SMA50 $60.38; +18.5% 60-day trend and XLF is positive today. Q2 revenue $31.6B, net income $9.1B, EPS $1.21, but near-term relative strength is weak. No add. Stop $60.70; targets $65.20/$67. Exit if $60.70 breaks or weakness persists.

## Fresh candidates and rotation test

1. **COP — 12/16, watch/retest.** +12.2% 20-day/+15.7% 60-day; above rising SMA20/SMA50 and printed a 52-week high today. Q2 EPS $3.24 beat $2.90, revenue +32.4%, operating cash flow $7.2B, and guidance was reaffirmed. Rejected now because it is extended at breakout resistance while XLE is lagging; wait for an orderly $130–132 retest. Illustrative plan only: trigger hold $132, stop $127, T1 $140, T2 $145 (1.6/2.6 R:R).
2. **PLTR — 12/16, watch/retest.** +41.0% 20-day/+27.3% 60-day, above rising SMA20/SMA50; Q2 revenue +93% and raised full-year guidance are strong catalysts. At $180.205 after +3.6% today, ~149x P/E and ~5.3% ATR make the entry extended. Wait for $170–174 support/retest; no chase.
3. **MA — 14/16, already held.** Best quality-adjusted trend, but near resistance and already represented; no add.
4. **ORCL — 10/16, watch only.** +18.4% 20-day but -26.4% 60-day and below SMA50; today's +3.3% bounce lacks a confirmed multi-session trend repair.
5. **GOOGL — 9/16, no trade.** Attractive ~17x P/E and +1.4% today, but below SMA20/SMA50 with negative 60-day momentum; not a qualifying continuation.

No fresh candidate reached 13+ with a confirmed, non-extended entry and materially better risk-adjusted evidence than BAC after accounting for slippage, thesis uncertainty, and the four-position cap. Rotating into COP/PLTR now would chase an extension; no churn was justified.

## Capital, reserve, and actions

- Pending/open-order reserve: $0. Liquid buying power after pending orders: $13.96.
- The 2026-08-20 entry deployed exactly 80% of the then-available $69.79 and left $13.96 as the protected 20% reserve. Recursively spending 80% of that reserve would violate policy.
- Current equity deployment: $313.81 / $327.77 = 95.74%; cash reserve $13.96 = 4.26% of total account value.
- **Actions:** no order reviews, placements, cancellations, trims, exits, or additions. No new fills.
- Management triggers: MA $561; BAC $60.70; XOM $163.50; SHOP $140. Fractional stops remain scheduled-scan management triggers because persistent fractional stop orders are not supported on this broker path.
